A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome
- 10 September 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Human Genetics
- Vol. 49 (11), 591-595
- https://doi.org/10.1007/s10038-004-0193-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patientsJournal of Medical Genetics, 2004
- 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 HospitalsCancer Research and Treatment, 2004
- Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?Journal of Medical Genetics, 2003
- E‐cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancerInternational Journal of Cancer, 2002
- Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindredHuman Mutation, 2002
- The Li–Fraumeni syndromeBiochimie, 2002
- Relative frequency and morphology of cancers in carriers of germline TP53 mutationsOncogene, 2001
- A novel germ line juxtamembrane Met mutation in human gastric cancerOncogene, 2000
- Germline mutations of E-cadherin gene in Korean familial gastric cancer patientsJournal of Human Genetics, 1999
- TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosisOncogene, 1997